www.fdanews.com/articles/114194-bioms-multiple-sclerosis-drug-fails-mid-stage-study
BioMS Multiple Sclerosis Drug Fails Mid-Stage Study
January 30, 2009
Canada’s BioMS Medical Corp said its lead drug for the treatment of multiple sclerosis failed to meet the main goal of a mid-stage study.
Interactive Investor
Interactive Investor